Sector Chart Scholar Rock Holding Corporation

Stocks

SRRK

US80706P1030

Biotechnology & Medical Research

Real-time Estimate Cboe BZX 02:27:39 2026-09-15 pm EDT			5-day change	1st Jan Change
47.66 ^USD	-8.08%		-17.88%	+7.05%

06:18am	Barclays Downgrades Scholar Rock to Equalweight From Overweight, Adjusts PT to $58 From $55	MT
Sep. 14	Scholar Rock's Early FDA Approval on Spinal Muscular Atrophy Drug Seen as 'Positive Surprise,' UBS Says	MT

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Sector Bio Therapeutic Drugs

	Capi.	Sales Growth	Profitability	Finances	EV / Sales	P/E
SCHOLAR ROCK HOLDING CORPORATION	6.31B	-	-	-	-	-
WUXI APPTEC CO., LTD.	70.24B
ARGENX SE	62.63B
INSMED INCORPORATED	27.36B					-
WUXI BIOLOGICS (CAYMAN) INC.	25.71B
BIONTECH SE	24.83B					-